AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency (Q45885080)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency |
scientific article |
Statements
1 reference
AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency (English)
1 reference
Stefan F C Vaessen
1 reference
Robert Jan Veldman
1 reference
Elisabeth M Comijn
1 reference
Jolanda Snapper
1 reference
Jeroen A Sierts
1 reference
Karin van den Oever
1 reference
Stuart G Beattie
1 reference
Jaap Twisk
1 reference
Jan Albert Kuivenhoven
1 reference
1 August 2009
1 reference
11
1 reference
8
1 reference
697-707
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference